Summary for 6YYQ
Entry DOI | 10.2210/pdb6yyq/pdb |
Descriptor | Cathepsin S, (6~{R})-2-phenyl-5,6,7,8-tetrahydroquinazolin-6-amine (3 entities in total) |
Functional Keywords | cathepsin s, inhibitor, hydrolase |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 4 |
Total formula weight | 101100.55 |
Authors | Wagener, M.,Schade, M.,Merla, B.,Hars, U.,Kueckelhaus, S.Q. (deposition date: 2020-05-05, release date: 2021-05-12, Last modification date: 2024-10-16) |
Primary citation | Schade, M.,Merla, B.,Lesch, B.,Wagener, M.,Timmermanns, S.,Pletinckx, K.,Hertrampf, T. Highly Selective Sub-Nanomolar Cathepsin S Inhibitors by Merging Fragment Binders with Nitrile Inhibitors. J.Med.Chem., 63:11801-11808, 2020 Cited by PubMed Abstract: Pharmacological inhibition of cathepsin S (CatS) allows for a specific modulation of the adaptive immune system and many major diseases. Here, we used NMR fragment screening and crystal structure-aided merging to synthesize novel, highly selective CatS inhibitors with picomolar enzymatic Ki values and nanomolar functional activity in human Raji cells. Noncovalent fragment hits revealed binding hotspots, while the covalent inhibitor structure-activity relationship enabled efficient potency optimization. PubMed: 32880457DOI: 10.1021/acs.jmedchem.0c00949 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.51 Å) |
Structure validation
Download full validation report
